SV
TVGN icon

Starboard Value’s Tevogen Bio Holdings TVGN Stock Holding History

Starboard Value’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,410
Closed -$4.34M – 112
2022
Q4 		$4.34M Hold
8,410
– – 0.08% 86
2022
Q3 		$4.27M Hold
8,410
– – 0.09% 98
2022
Q2 		$4.21M Hold
8,410
– – 0.08% 101
2022
Q1 		$4.2M Buy
+8,410
New +$4.18M 0.06% 94

Other funds holding TVGN

CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Starboard Value's TVGN Position: Q1 2023 in Review

Starboard Value sold out of Tevogen Bio Holdings (TVGN) in Q1 2023, closing a stake of 8,410 shares — an estimated $4.34M sold.

Starboard Value first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $4.34M in Q4 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

  • Starboard Value reported no remaining Tevogen Bio Holdings position as of Q1 2023 after selling out during the quarter.
  • Starboard Value sold 8,410 Tevogen Bio Holdings shares in Q1 2023, an estimated $4.34M.
  • Starboard Value first reported a position in Tevogen Bio Holdings in Q1 2022 and held it in 4 quarters.
  • Starboard Value's Tevogen Bio Holdings position peaked at $4.34M in Q4 2022.
  • 4 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2023.

Based on Starboard Value's 13F filing for Q1 2023, filed 12 May 2023.